TITA

COM:TITANBIOTECHLTD

Titan Biotech Ltd.

  • Stock

INR

Last Close

765.50

25/11 09:25

Market Cap

4.96B

Beta: -

Volume Today

4.38K

Avg: -

Company Overview

Metric
Company NameTitan Biotech LimitedStarplex Scientific
SymbolTITANBIO
MSH IDCOM:TITANBIOTECHLTDCOM:STARPLEXSCIENTIFIC
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryBiotechnologyMedical Devices
CountryINCA
Stage
Employee Count396
Websitetitanbiotechltd.comstarplexscientific.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap58.60M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue19.37M
Revenue (LTM)
Revenue (NTM)
Gross Profit7.25M
EBITDA4.05M
Operating Income3.65M
Net Income2.93M
EPS0.36
Diluted EPS0.36
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.54
Operating Profit Margin0.19
EBITDA Margin0.21
Net Profit Margin0.15
Return on Equity0.44
Return on Assets0.16
Return on Capital Employed0.23

Valuation Multiples

Metric
P/E Ratio16.96
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio4.79
EV Multiple23.04

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding199.80
Operating Cycle241.31
Cash Conversion Cycle226.54
Asset Turnover1.10

Cash Flow Metrics

Metric
Operating Cash Flow2.36M
Free Cash Flow1.30M
Cash Flow to Debt2.54
Operating Cash Flow/Sales0.12
Free Cash Flow Yield0.05

Balance Sheet Metrics

Metric
Cash & Equivalents335.31K
Accounts Receivable416.60K
Inventory5.38M
Goodwill
Debt to Capitalization0.05
Debt to Assets
Current Ratio
Quick Ratio1.39

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue